HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert J Plunkett Selected Research

CBLC137

1/2017Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert J Plunkett Research Topics

Disease

6Neoplasms (Cancer)
10/2019 - 09/2004
6Glioblastoma (Glioblastoma Multiforme)
01/2017 - 03/2004
3Glioma (Gliomas)
12/2010 - 08/2006
2Brain Neoplasms (Brain Tumor)
01/2016 - 02/2008
1Spasm (Spasms)
04/2009
1Pain (Aches)
03/2005
1Astrocytoma (Pilocytic Astrocytoma)
03/2004

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
01/2017 - 01/2016
2Estradiol (Delestrogen)FDA LinkGeneric
10/2009 - 09/2004
1Histone ChaperonesIBA
01/2017
1CBLC137IBA
01/2017
1Temozolomide (Temodar)FDA LinkGeneric
01/2017
1Proteins (Proteins, Gene)FDA Link
12/2010
1Therapeutic UsesIBA
10/2009
1Estrogens (Estrogen)FDA Link
10/2009
1estrophilinIBA
10/2009
1BaclofenFDA LinkGeneric
04/2009
1OsteopontinIBA
02/2008
1Complementary DNA (cDNA)IBA
02/2008
1Transforming Growth Factor-beta Type II ReceptorIBA
08/2006
1Transforming Growth Factor beta1 (TGF beta 1)IBA
08/2006
1Phosphotransferases (Kinase)IBA
08/2006
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
08/2006
12-MethoxyestradiolIBA
09/2004
1Protein Isoforms (Isoforms)IBA
03/2004

Therapy/Procedure

1Radiotherapy
10/2019
1Intravenous Administration
01/2017
1Therapeutics
01/2016
1Time-to-Treatment
03/2005
1Aftercare (After-Treatment)
03/2005